The latest coronavirus developments and scientific research on prevention and treatment.
Biogen announced that the European Commission (EC) has granted marketing authorization for a subcutaneous (SC) injection of Tysabri (natalizumab) to treat relapsing-remitting multiple sclerosis (MS).
Abusive alcohol drinking considerably impacts human health. Alcoholism, better defined as Alcohol Use Disorders (AUD), includes a group of pathological entities related to alcohol-induced damage. Individuals with AUD… read more.
The AstraZeneca US Phase III trial of AZD 1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease and… read more.
Interview and article by Christine Clark. Community pharmacies are at the heart of their communities and can contribute to the Vac4covid study by signposting patients to the website,… read more.
Interview and article by Christine Clark. Gavin Dobson, Clinical Trials Pharmacist at MEMO Research explains the practical details of the Vac4covid study. The Vac4covid study will recruit at… read more.
Interview and article by Christine Clark. The Vac4covid study has been designed to provide important data about the safety and effectiveness of covid-19 vaccines. IMI interviewed Mr Gavin… read more.
Pfizer Inc. and BioNTech SE announced that, in a Phase III trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection,… read more.
Celltrion Group announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for the company’s anti-COVID-19 monoclonal antibody… read more.
ASHP (American Society of Health-System Pharmacists) today announced the publication of two landmark reports that articulate a futuristic vision for pharmacy practice, including expanded roles for the pharmacy enterprise… read more.
Study taken throughout the pandemic shows those who feel government should be less controlling believe COVID-19 poses less risk, which in turn was associated with the adoption of… read more.
Positive high-level results from the primary analysis of the Phase III trial of AZD 1222 in the US have confirmed vaccine efficacy consistent with the pre-specified interim analysis… read more.
Interview and article by Christine Clark. The real world evidence about ivermectin combined with the findings from meta-analyses of clinical trials provide compelling evidence for the safety and… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
